Trial intelligence / Profile preview

G-CSF in Repeated Implantation Failure

NCT02149277Phase 3Terminated

Sponsor
clinique ovo
Start
Mar 2013
Primary completion
Dec 2017
Modality
Cytokines & Interferons
Countries
1
01

Overview

A Phase 3 trial of filgrastim in Embryo Implantation Failure, sponsored by clinique ovo. Started Mar 2013; status: terminated.

02

Drugs

filgrastim
03

Conditions

Embryo Implantation Failure

Beyond the preview

Go deeper on NCT02149277.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02149277.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call